Sai Siddhi Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 8.00 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.42 Cr
- Satisfied Charges ₹ 1.95 Cr
- Revenue Growth 5.15%
- Profit Growth -18.24%
- Ebitda -30.71%
- Net Worth 50.15%
- Total Assets -0.14%
About Sai Siddhi Pharmachem
Sai Siddhi Pharmachem Private Limited (SSPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 December 2013 and has a history of 11 years and two months. Its registered office is in Bharuch, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹4.42 Cr. The company has closed loans amounting to ₹1.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Umang Bhadresh, Smrutiben Valavi, and Manishkumar Patel serve as directors at the Company.
Company Details
-
Location
Bharuch, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2013PTC077705
-
Company No.
077705
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Dec 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sai Siddhi Pharmachem?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umang Bhadresh
|
Director | 02-Dec-2013 | Current |
|
Smrutiben Valavi
|
Director | 02-Dec-2013 | Current |
|
Manishkumar Patel
|
Director | 01-Jan-2014 | Current |
Financial Performance of Sai Siddhi Pharmachem.
Sai Siddhi Pharmachem Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 5.15% increase. The company also saw a substantial fall in profitability, with a 18.24% decrease in profit. The company's net worth Soared by an impressive increase of 50.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Siddhi Pharmachem?
In 2020, Sai Siddhi Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹44.16 M
₹19.50 M
Charges Breakdown by Lending Institutions
- Others : 4.42 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Aug 2021 | Others | ₹2.11 Cr | Open |
| 11 Feb 2020 | Others | ₹2.30 Cr | Open |
| 05 Dec 2014 | Canara Bank | ₹1.95 Cr | Satisfied |
How Many Employees Work at Sai Siddhi Pharmachem?
Sai Siddhi Pharmachem has a workforce of 16 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Siddhi Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Siddhi Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
